Massimo Colombo
Massimo Colombo
Email verificata su
Citata da
Citata da
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of The Liver
Journal of hepatology 56 (4), 908-943, 2012
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference
J Bruix, M Sherman, JM Llovet, M Beaugrand, R Lencioni, AK Burroughs, ...
Journal of hepatology 35 (3), 421-430, 2001
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
G Kuo, QL Choo, HJ Alter, GL Gitnick, AG Redeker, RH Purcell, ...
Science 244 (4902), 362-364, 1989
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati, E Taioli, A Zanella, ED Torre, S Butelli, E Del Vecchio, L Vianello, ...
Annals of internal medicine 137 (1), 1-10, 2002
Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies
F Piccinino, E Sagnelli, G Pasquale, G Giusti, A Battocchia, M Bernardi, ...
Journal of hepatology 2 (2), 165-173, 1986
A proposed system for the nomenclature of hepatitis C viral genotypes
P Simmonds, A Alberti, HJ Alter, F Bonino, DW Bradley, C Brechot, ...
Hepatology 19 (5), 1321-1324, 1994
Hepatocellular carcinoma in Italian patients with cirrhosis
M Colombo, R De Franchis, E Del Ninno, A Sangiovanni, C De Fazio, ...
New England Journal of Medicine 325 (10), 675-680, 1991
Statements from the Taormina expert meeting on occult hepatitis B virus infection
G Raimondo, JP Allain, MR Brunetto, MA Buendia, DS Chen, M Colombo, ...
Journal of hepatology 49 (4), 652-657, 2008
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease
M Fraquelli, C Rigamonti, G Casazza, D Conte, MF Donato, G Ronchi, ...
Gut 56 (7), 968-973, 2007
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
M Colombo, QL Choo, E Del Ninno, N Dioguardi, G Kuo, MF Donato, ...
The Lancet 334 (8670), 1006-1008, 1989
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study
S Bruno, T Stroffolini, M Colombo, S Bollani, L Benvegnu, G Mazzella, ...
Hepatology 45 (3), 579-587, 2007
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance
A Sangiovanni, E Del Ninno, P Fasani, C De Fazio, G Ronchi, R Romeo, ...
Gastroenterology 126 (4), 1005-1014, 2004
The natural history of compensated cirrhosis due to hepatitis C virus: a 17‐year cohort study of 214 patients
A Sangiovanni, GM Prati, P Fasani, G Ronchi, R Romeo, M Manini, ...
Hepatology 43 (6), 1303-1310, 2006
A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon
G Fattovich, G Giustina, S Favarato, A Ruol
Journal of hepatology 24 (1), 38-47, 1996
Hepatitis C virus type 1b (II) infection in France and Italy
JB Nousbaum, S Pol, B Nalpas, P Landais, P Berthelot, C Brechot
Annals of internal medicine 122 (3), 161-168, 1995
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre–and post–liver transplantation patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
JM Llovet, R Lencioni, AM Di Bisceglie, PR Gaile, JF Dufour, TF Greten, ...
Journal of hepatology 56 (4), 908-943, 2012
EASL international consensus conference on hepatitis B 13-14 September, 2002 Geneva, Switzerland Consensus statement (Long version)
R De Franchis, A Hadengue, G Lau, D Lavanchy, A Lok, N McIntyre, ...
Journal of Hepatology 39 (SUPPL. 1), 2003
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype…
P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ...
Gastroenterology 147 (2), 359-365. e1, 2014
AASLD practice guideline
J Bruix, M Sherman
Management of hepatocellular carcinoma. Hepatology 42 (5), 1208-1236, 2005
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20